Combination antibacterial therapy enhances survival and reduces early mortality in critically ill patients with severe pneumococcal bacteraemia

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1456, 2004-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hyperglycaemia, insulin increase mortality in critically ill patients

By  

Inpharma, Vol. 1, Iss. 1410, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Clinical Potential of Insulin Therapy in Critically Ill Patients

By Mesotten D.   Berghe G.V.d.  

Drugs, Vol. 63, Iss. 7, 2003-01 ,pp. : 625-636

Adis International

Access to resources Recommend Favorite

The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients

By Ulldemolins Marta   Roberts Jason A.   Rello Jordi   Paterson David L.   Lipman Jeffrey  

Clinical Pharmacokinetics, Vol. 50, Iss. 2, 2011-02 ,pp. : 99-110

Adis International

Access to resources Recommend Favorite

Epoetin-α may reduce mortality in critically ill patients

By  

Inpharma, Vol. 1, Iss. 1605, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Biomarkers upon discontinuation of renal replacement therapy predict 60‐day survival and renal recovery in critically ill patients with acute kidney injury

By  

Hemodialysis International, Vol. 22, Iss. 1, 2018-01 ,pp. : 56-65

John Wiley & Sons Inc

Access to resources Recommend Favorite